ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0135714101922724 0.28335086
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0139796580235794 0.3465402
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0139796580235794 0.47305191
NSC 303861 L-Cysteine analog 0.0139796580235794 0.63249053
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0139796580235794 0.5609273
NSC 328410 Camptothecin Derivative 0.0139796580235794 -0.096286671
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0139796580235794 0.19499872
NSC 39215 Null 0.0139796580235794 0.6193446
NSC 42972 Null 0.0139796580235794 0.55644278
NSC 617394 Null 0.0139796580235794 0.47920585
Total:136  Current:63    [First] [Prev] [Next] [Last]